A Study of TRK-950 in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivolumab and Ipilimumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Fedratinib in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE2
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
- Status
- RECRUITING
- Phase
- PHASE2
A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase II Trial of Immunotherapy in Patients With Carcinomas Arising From the Renal Medulla
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy of VTP-300 in Chronic Hepatitis B Infection
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Status
- RECRUITING
- Phase
- PHASE2
Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
- Status
- RECRUITING
- Phase
- PHASE3
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2